 | • レポートコード：MRC2102QY9686 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医療機器 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の次世代がん診断装置市場について種類別（次世代シーケンシング、qPCR・マルチプレックス、ラボオンチップ（LOAC）、タンパク質マイクロアレイ、DNAマイクロアレイ、逆転写酵素PCR（RT-PCR））、用途別（バイオマーカー開発、CTC分析、プロテオミクス分析、エピジェネティック分析、遺伝子分析）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・次世代がん診断装置市場の概要 ・世界の主要地域別次世代がん診断装置市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の次世代がん診断装置市場規模2015-2026：種類別（次世代シーケンシング、qPCR・マルチプレックス、ラボオンチップ（LOAC）、タンパク質マイクロアレイ、DNAマイクロアレイ、逆転写酵素PCR（RT-PCR）） ・世界の次世代がん診断装置市場規模2015-2026：用途別（バイオマーカー開発、CTC分析、プロテオミクス分析、エピジェネティック分析、遺伝子分析） ・次世代がん診断装置の米国市場規模2015-2020 ・次世代がん診断装置のヨーロッパ市場規模2015-2020 ・次世代がん診断装置の中国市場規模2015-2020 ・次世代がん診断装置の日本市場規模2015-2020 ・次世代がん診断装置の東南アジア市場規模2015-2020 ・次世代がん診断装置のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・次世代がん診断装置の製造コスト分析 ・販売チャネル、流通業者、顧客 ・次世代がん診断装置の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Next Generation Cancer Diagnostic Devices Market
The global Next Generation Cancer Diagnostic Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Next Generation Cancer Diagnostic Devices Scope and Market Size
The global Next Generation Cancer Diagnostic Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Cancer Diagnostic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Next Generation Cancer Diagnostic Devices market is segmented into
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC)
Protein Microarrays
DNA Microarrays
Reverse Transcriptase-PCR (RT-PCR)
Segment by Application, the Next Generation Cancer Diagnostic Devices market is segmented into
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
The Next Generation Cancer Diagnostic Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Next Generation Cancer Diagnostic Devices market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Next Generation Cancer Diagnostic Devices Market Share Analysis
Next Generation Cancer Diagnostic Devices market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Next Generation Cancer Diagnostic Devices business, the date to enter into the Next Generation Cancer Diagnostic Devices market, Next Generation Cancer Diagnostic Devices product introduction, recent developments, etc.
The major vendors covered:
Roche Holding Ltd.（Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)
1 Next Generation Cancer Diagnostic Devices Market Overview
1.1 Next Generation Cancer Diagnostic Devices Product Scope
1.2 Next Generation Cancer Diagnostic Devices Segment by Type
1.2.1 Global Next Generation Cancer Diagnostic Devices Sales by Type (2020-2026)
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 Lab-on- a- chip (LOAC)
1.2.5 Protein Microarrays
1.2.6 DNA Microarrays
1.2.7 Reverse Transcriptase-PCR (RT-PCR)
1.3 Next Generation Cancer Diagnostic Devices Segment by Application
1.3.1 Global Next Generation Cancer Diagnostic Devices Sales Comparison by Application (2020-2026)
1.3.2 Biomarker Development
1.3.3 CTC Analysis
1.3.4 Proteomic Analysis
1.3.5 Epigenetic Analysis
1.3.6 Genetic Analysis
1.4 Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts (2015-2026)
1.4.1 Global Next Generation Cancer Diagnostic Devices Sales Growth Rate (2015-2026)
1.4.2 Global Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2015-2026)
1.4.3 Global Next Generation Cancer Diagnostic Devices Price Trends (2015-2026)
2 Next Generation Cancer Diagnostic Devices Estimate and Forecast by Region
2.1 Global Next Generation Cancer Diagnostic Devices Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2015-2020)
2.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2015-2020)
2.3 Global Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Next Generation Cancer Diagnostic Devices Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Next Generation Cancer Diagnostic Devices Estimates and Projections (2015-2026)
2.4.2 Europe Next Generation Cancer Diagnostic Devices Estimates and Projections (2015-2026)
2.4.3 China Next Generation Cancer Diagnostic Devices Estimates and Projections (2015-2026)
2.4.4 Japan Next Generation Cancer Diagnostic Devices Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Next Generation Cancer Diagnostic Devices Estimates and Projections (2015-2026)
2.4.6 India Next Generation Cancer Diagnostic Devices Estimates and Projections (2015-2026)
3 Global Next Generation Cancer Diagnostic Devices Competition Landscape by Players
3.1 Global Top Next Generation Cancer Diagnostic Devices Players by Sales (2015-2020)
3.2 Global Top Next Generation Cancer Diagnostic Devices Players by Revenue (2015-2020)
3.3 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2019)
3.4 Global Next Generation Cancer Diagnostic Devices Average Price by Company (2015-2020)
3.5 Manufacturers Next Generation Cancer Diagnostic Devices Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Next Generation Cancer Diagnostic Devices Players (Opinion Leaders)
4 Global Next Generation Cancer Diagnostic Devices Market Size by Type
4.1 Global Next Generation Cancer Diagnostic Devices Historic Market Review by Type (2015-2020)
4.1.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
4.1.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2015-2020)
4.1.3 Global Next Generation Cancer Diagnostic Devices Price by Type (2015-2020)
4.2 Global Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2021-2026)
4.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2021-2026)
4.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Type (2021-2026)
5 Global Next Generation Cancer Diagnostic Devices Market Size by Application
5.1 Global Next Generation Cancer Diagnostic Devices Historic Market Review by Application (2015-2020)
5.1.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
5.1.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Application (2015-2020)
5.1.3 Global Next Generation Cancer Diagnostic Devices Price by Application (2015-2020)
5.2 Global Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2021-2026)
5.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Application (2021-2026)
5.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Application (2021-2026)
6 United States Next Generation Cancer Diagnostic Devices Market Facts & Figures
6.1 United States Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
6.2 United States Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
6.3 United States Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
7 Europe Next Generation Cancer Diagnostic Devices Market Facts & Figures
7.1 Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
7.2 Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
7.3 Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
8 China Next Generation Cancer Diagnostic Devices Market Facts & Figures
8.1 China Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
8.2 China Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
8.3 China Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
9 Japan Next Generation Cancer Diagnostic Devices Market Facts & Figures
9.1 Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Company (3015-3030)
9.2 Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
9.3 Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
10 Southeast Asia Next Generation Cancer Diagnostic Devices Market Facts & Figures
10.1 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
11 India Next Generation Cancer Diagnostic Devices Market Facts & Figures
11.1 India Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
11.2 India Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
11.3 India Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Next Generation Cancer Diagnostic Devices Business
12.1 Roche Holding Ltd.（Switzerland)
12.1.1 Roche Holding Ltd.（Switzerland) Corporation Information
12.1.2 Roche Holding Ltd.（Switzerland) Business Overview
12.1.3 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Products Offered
12.1.5 Roche Holding Ltd.（Switzerland) Recent Development
12.2 Abbott Laboratories(US)
12.2.1 Abbott Laboratories(US) Corporation Information
12.2.2 Abbott Laboratories(US) Business Overview
12.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Products Offered
12.2.5 Abbott Laboratories(US) Recent Development
12.3 Siemens Healthcare(Germany)
12.3.1 Siemens Healthcare(Germany) Corporation Information
12.3.2 Siemens Healthcare(Germany) Business Overview
12.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Products Offered
12.3.5 Siemens Healthcare(Germany) Recent Development
12.4 Agilent Technologies Inc(Germany)
12.4.1 Agilent Technologies Inc(Germany) Corporation Information
12.4.2 Agilent Technologies Inc(Germany) Business Overview
12.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Products Offered
12.4.5 Agilent Technologies Inc(Germany) Recent Development
12.5 Illumina Inc.(US)
12.5.1 Illumina Inc.(US) Corporation Information
12.5.2 Illumina Inc.(US) Business Overview
12.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.5.5 Illumina Inc.(US) Recent Development
12.6 Becton Dickinson and Co.(US)
12.6.1 Becton Dickinson and Co.(US) Corporation Information
12.6.2 Becton Dickinson and Co.(US) Business Overview
12.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.6.5 Becton Dickinson and Co.(US) Recent Development
12.7 QIAGEN N.V.(Germany)
12.7.1 QIAGEN N.V.(Germany) Corporation Information
12.7.2 QIAGEN N.V.(Germany) Business Overview
12.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Products Offered
12.7.5 QIAGEN N.V.(Germany) Recent Development
12.8 Affymetrix Inc.(US)
12.8.1 Affymetrix Inc.(US) Corporation Information
12.8.2 Affymetrix Inc.(US) Business Overview
12.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.8.5 Affymetrix Inc.(US) Recent Development
12.9 Johnson & Johnson(US)
12.9.1 Johnson & Johnson(US) Corporation Information
12.9.2 Johnson & Johnson(US) Business Overview
12.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Products Offered
12.9.5 Johnson & Johnson(US) Recent Development
12.10 Thermo Fisher Scientific Inc.(US)
12.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
12.10.2 Thermo Fisher Scientific Inc.(US) Business Overview
12.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
12.11 GE Healthcare(England)
12.11.1 GE Healthcare(England) Corporation Information
12.11.2 GE Healthcare(England) Business Overview
12.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Products Offered
12.11.5 GE Healthcare(England) Recent Development
12.12 Life Technologies Corp.(US)
12.12.1 Life Technologies Corp.(US) Corporation Information
12.12.2 Life Technologies Corp.(US) Business Overview
12.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.12.5 Life Technologies Corp.(US) Recent Development
12.13 Luminex Corp.(US)
12.13.1 Luminex Corp.(US) Corporation Information
12.13.2 Luminex Corp.(US) Business Overview
12.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.13.5 Luminex Corp.(US) Recent Development
12.14 Cepheid Inc.(US)
12.14.1 Cepheid Inc.(US) Corporation Information
12.14.2 Cepheid Inc.(US) Business Overview
12.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
12.14.5 Cepheid Inc.(US) Recent Development
12.15 Allegro Diagnostics Corp.(Brazil)
12.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
12.15.2 Allegro Diagnostics Corp.(Brazil) Business Overview
12.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Products Offered
12.15.5 Allegro Diagnostics Corp.(Brazil) Recent Development
13 Next Generation Cancer Diagnostic Devices Manufacturing Cost Analysis
13.1 Next Generation Cancer Diagnostic Devices Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
13.4 Next Generation Cancer Diagnostic Devices Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Next Generation Cancer Diagnostic Devices Distributors List
14.3 Next Generation Cancer Diagnostic Devices Customers
15 Market Dynamics
15.1 Next Generation Cancer Diagnostic Devices Market Trends
15.2 Next Generation Cancer Diagnostic Devices Opportunities and Drivers
15.3 Next Generation Cancer Diagnostic Devices Market Challenges
15.4 Next Generation Cancer Diagnostic Devices Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Next Generation Cancer Diagnostic Devices Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Region (2015-2020)
Table 5. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2015-2020)
Table 6. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Next Generation Cancer Diagnostic Devices Revenue Share by Region (2015-2020)
Table 8. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Next Generation Cancer Diagnostic Devices Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Next Generation Cancer Diagnostic Devices Revenue Share Forecast by Region (2021-2026)
Table 12. Global Next Generation Cancer Diagnostic Devices (K Pcs) of Key Companies (2015-2020)
Table 13. Global Next Generation Cancer Diagnostic Devices Sales Share by Company (2015-2020)
Table 14. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Next Generation Cancer Diagnostic Devices Revenue Share by Company (2015-2020)
Table 16. Global Next Generation Cancer Diagnostic Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2019)
Table 17. Global Next Generation Cancer Diagnostic Devices Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Next Generation Cancer Diagnostic Devices Manufacturing Sites and Area Served
Table 19. Manufacturers Next Generation Cancer Diagnostic Devices Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Next Generation Cancer Diagnostic Devices Players
Table 22. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2015-2020)
Table 23. Global Next Generation Cancer Diagnostic Devices Sales Share by Type (2015-2020)
Table 24. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Next Generation Cancer Diagnostic Devices Price (K Pcs) by Type (2015-2020)
Table 26. Global Next Generation Cancer Diagnostic Devices Sales Share by Type (2021-2026)
Table 27. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Next Generation Cancer Diagnostic Devices Revenue Share by Type (2021-2026)
Table 29. Global Next Generation Cancer Diagnostic Devices Price (K Pcs) by Type (2021-2026)
Table 30. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2015-2020)
Table 31. Global Next Generation Cancer Diagnostic Devices Sales Share by Application (2015-2020)
Table 32. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Next Generation Cancer Diagnostic Devices Price (K Pcs) by Application (2015-2020)
Table 34. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2021-2026)
Table 35. Global Next Generation Cancer Diagnostic Devices Sales Share by Application (2021-2026)
Table 36. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Next Generation Cancer Diagnostic Devices Revenue Share by Application (2021-2026)
Table 38. Global Next Generation Cancer Diagnostic Devices Price (K Pcs) by Application (2021-2026)
Table 39. United States Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2015-2020)
Table 40. United States Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
Table 41. United States Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2015-2020)
Table 42. United States Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
Table 43. United States Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2015-2020)
Table 44. United States Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
Table 45. Europe Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
Table 47. Europe Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
Table 49. Europe Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
Table 51. China Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2015-2020)
Table 52. China Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
Table 53. China Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2015-2020)
Table 54. China Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
Table 55. China Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2015-2020)
Table 56. China Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
Table 57. Japan Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
Table 59. Japan Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
Table 61. Japan Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
Table 69. India Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Company (2015-2020)
Table 70. India Next Generation Cancer Diagnostic Devices Sales Market Share by Company (2015-2020)
Table 71. India Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Type (2015-2020)
Table 72. India Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2015-2020)
Table 73. India Next Generation Cancer Diagnostic Devices Sales (K Pcs) by Application (2015-2020)
Table 74. India Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2015-2020)
Table 75. Roche Holding Ltd.（Switzerland) Corporation Information
Table 76. Roche Holding Ltd.（Switzerland) Description and Business Overview
Table 77. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Product
Table 79. Roche Holding Ltd.（Switzerland) Recent Development
Table 80. Abbott Laboratories(US) Corporation Information
Table 81. Abbott Laboratories(US) Description and Business Overview
Table 82. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product
Table 84. Abbott Laboratories(US) Recent Development
Table 85. Siemens Healthcare(Germany) Corporation Information
Table 86. Siemens Healthcare(Germany) Description and Business Overview
Table 87. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product
Table 89. Siemens Healthcare(Germany) Recent Development
Table 90. Agilent Technologies Inc(Germany) Corporation Information
Table 91. Agilent Technologies Inc(Germany) Description and Business Overview
Table 92. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product
Table 94. Agilent Technologies Inc(Germany) Recent Development
Table 95. Illumina Inc.(US) Corporation Information
Table 96. Illumina Inc.(US) Description and Business Overview
Table 97. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 99. Illumina Inc.(US) Recent Development
Table 100. Becton Dickinson and Co.(US) Corporation Information
Table 101. Becton Dickinson and Co.(US) Description and Business Overview
Table 102. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product
Table 104. Becton Dickinson and Co.(US) Recent Development
Table 105. QIAGEN N.V.(Germany) Corporation Information
Table 106. QIAGEN N.V.(Germany) Description and Business Overview
Table 107. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product
Table 109. QIAGEN N.V.(Germany) Recent Development
Table 110. Affymetrix Inc.(US) Corporation Information
Table 111. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Affymetrix Inc.(US) Description and Business Overview
Table 113. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 114. Affymetrix Inc.(US) Recent Development
Table 115. Johnson & Johnson(US) Corporation Information
Table 116. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Johnson & Johnson(US) Description and Business Overview
Table 118. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product
Table 119. Johnson & Johnson(US) Recent Development
Table 120. Thermo Fisher Scientific Inc.(US) Corporation Information
Table 121. Thermo Fisher Scientific Inc.(US) Description and Business Overview
Table 122. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 124. Thermo Fisher Scientific Inc.(US) Recent Development
Table 125. GE Healthcare(England) Corporation Information
Table 126. GE Healthcare(England) Description and Business Overview
Table 127. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product
Table 129. GE Healthcare(England) Recent Development
Table 130. Life Technologies Corp.(US) Corporation Information
Table 131. Life Technologies Corp.(US) Description and Business Overview
Table 132. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product
Table 134. Life Technologies Corp.(US) Recent Development
Table 135. Luminex Corp.(US) Corporation Information
Table 136. Luminex Corp.(US) Description and Business Overview
Table 137. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product
Table 139. Luminex Corp.(US) Recent Development
Table 140. Cepheid Inc.(US) Corporation Information
Table 141. Cepheid Inc.(US) Description and Business Overview
Table 142. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product
Table 144. Cepheid Inc.(US) Recent Development
Table 145. Allegro Diagnostics Corp.(Brazil) Corporation Information
Table 146. Allegro Diagnostics Corp.(Brazil) Description and Business Overview
Table 147. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product
Table 149. Allegro Diagnostics Corp.(Brazil) Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Next Generation Cancer Diagnostic Devices Distributors List
Table 153. Next Generation Cancer Diagnostic Devices Customers List
Table 154. Next Generation Cancer Diagnostic Devices Market Key Trends
Table 155. Next Generation Cancer Diagnostic Devices Key Opportunities and Drivers
Table 156. Next Generation Cancer Diagnostic Devices Market Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Next Generation Cancer Diagnostic Devices Product Picture
Figure 2. Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Next Generation Cancer Diagnostic Devices Market Share by Application in 2020 & 2026
Figure 6. Biomarker Development Examples
Figure 7. CTC Analysis Examples
Figure 8. Proteomic Analysis Examples
Figure 9. Epigenetic Analysis Examples
Figure 10. Genetic Analysis Examples
Figure 11. Global Next Generation Cancer Diagnostic Devices Sales (K Pcs) Growth Rate (2015-2026)
Figure 12. Global Next Generation Cancer Diagnostic Devices Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Next Generation Cancer Diagnostic Devices Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 14. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Next Generation Cancer Diagnostic Devices Sales (K Pcs) Growth Rate (2015-2026)
Figure 18. Europe Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Next Generation Cancer Diagnostic Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Next Generation Cancer Diagnostic Devices Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Next Generation Cancer Diagnostic Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Next Generation Cancer Diagnostic Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Next Generation Cancer Diagnostic Devices Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Next Generation Cancer Diagnostic Devices Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Next Generation Cancer Diagnostic Devices Players Market Share by Revenue in Next Generation Cancer Diagnostic Devices 2015 & 2019
Figure 29. Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Next Generation Cancer Diagnostic Devices Revenue Share by Type (2015-2020)
Figure 31. Global Next Generation Cancer Diagnostic Devices Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Next Generation Cancer Diagnostic Devices Revenue Share by Application (2015-2020)
Figure 33. Global Next Generation Cancer Diagnostic Devices Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2019
Figure 35. United States Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2019
Figure 36. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Company in 2019
Figure 37. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2019
Figure 38. Europe Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2019
Figure 39. China Next Generation Cancer Diagnostic Devices Sales Market Share by Company in 2019
Figure 40. China Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2019
Figure 41. China Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2019
Figure 42. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Company in 2019
Figure 43. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2019
Figure 44. Japan Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2019
Figure 45. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Company in 2019
Figure 46. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2019
Figure 47. Southeast Asia Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2019
Figure 48. India Next Generation Cancer Diagnostic Devices Sales Market Share by Company in 2019
Figure 49. India Next Generation Cancer Diagnostic Devices Sales Market Share by Type in 2019
Figure 50. India Next Generation Cancer Diagnostic Devices Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Next Generation Cancer Diagnostic Devices
Figure 53. Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
Figure 54. Next Generation Cancer Diagnostic Devices Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
診断用心電図装置の世界市場レポート2020 Diagnostic Electrocardiography Devices continuous monitoring for cardiac events and abnormal heart rhythms, detection and treatment. As the number of aging population increases, people prone to cardiovascular disease also increases.Diagnostic Electrocardiography Devices Can effectively detect the di…- 聴覚診断装置の世界市場レポート2020 Hearing Diagnostic Devices is a machine used for hear testing and evaluating hearing loss .They usually consist of an embedded hardware unit connected to a pair of headphones and a test subject feedback button, sometimes controlled by a standard PC. In the next five years, the global consumption of …
- 睡眠時無呼吸診断装置の世界市場レポート2020 Sleep Apnea Diagnostic Devices is the equipment used to detect the apnea during the sleep time. With the growing aging population, the Sleep Apnea Diagnostic Devices market will continue to expand. At present, Chinese high end market is occupied by imported brands such as Philips. The domestic enter…
- 睡眠時無呼吸診断・治療装置の世界市場レポート2020 Sleep Apnea Diagnostic and Therapeutic Devices is the equipment used to detect the apnea during the sleep time. With the growing aging population, the Sleep Apnea Diagnostic and Therapeutic Devices market will continue to expand. At present, Chinese high end market is occupied by imported brands suc…
- 診断用超音波装置の世界市場レポート2020 Diagnostic ultrasound device is a special medical device used in ultrasonography for diagnostic purpose. Ultrasonography, commonly known as ultrasound, is a popular medical imaging technique used in diagnostics, and which uses high-frequency sound pulses and their echoes to specific body regions. Ul…